FOLFIRINOX in Patients With Inoperable Pancreatic Cancer

Stopped The principal investigator terminated the study due to inactivity and low enrollment

Conditions

• Adenocarcinoma of Pancreas

Interventions

• DRUG: Irinotecan, Oxaliplatin, Leucovorin, 5-FU

Sponsor

University of Oklahoma